ECGM內皮細胞培養基

完美替代所有進口低血清內皮細胞培養系列，ECGM內皮系列年銷破500套，國內現貨，1-2天左右可以發，試用裝付郵即送，購買正裝后退運費！點擊鏈接申請試用 http://www.fenghuangbao.cn/qdtrial/1.html

內皮細胞培養基是一種低血清內皮細胞完全培養基，適合血管內皮細胞和永生化的內皮細胞株。

內皮細胞培養基經10種人各部位的內皮細胞的測試和優化，經無菌，無支原體，無內毒素檢測，添加肝素，內皮生長因子，胰島素，抗氧化劑，皮質醇等組分，為了實現細胞的正常的新陳代謝過程，培養基盡量減少生長刺激的因子組分。

其中

P1001-NG是無糖的培養基系列，

P1001-NL是無谷氨酰胺的培養基系列，

P1001-M是小鼠內皮培養系列，

P1001-R是大鼠內皮系列

培養基配方：

基礎培養基：500ml(P1000)，細胞生長因子（ECGS）：5ml (P1002)，胎牛血清：25ml（SD0200），

G/A：5ml(SD0038）

培養基優勢：

1.BBB實驗首選共培養培養基，適用于大部分血管內皮細胞的培養，擴增和傳代，還分大小鼠和人源的哦。

2.細化分類，分為人源，大鼠源，小鼠源內皮培養系列。

3.大罐過濾灌裝，采用人工稱量后再進行自動稱量，保持各化學組分均衡反應與充分結合，保質期一年，避免存放過久氨基酸降解及激素變性。

4.采用小分子化合物抑制雜細胞生長，添加促內皮生長因子讓內皮細胞生長。

5.經60多種內皮細胞驗證生長速度；可平替進口品牌。

6.低血清組分減少血清在細胞內的干擾。

7.套裝發貨，配制簡單，使用方便。

聲明：產品僅科研使用。

參考文獻/Publications

1. PMID: 35369032  nternational Journal of Nanomedicine 2022:17 1397–1408  Combined Prussian Blue Nanozyme Carriers Improve Photodynamic Therapy and Effective Interruption of Tumor Metastasis

2. Pleiotropic Immunomodulatory Functions of Radioactive Inactivated Bacterial Vectors for Enhanced Cancer Radio-immunotherapy.ACS Nano 2022, 16, 7, 11325–11337 

https://doi.org/10.1021/acsnano.2c04982

3.Interleukin-19 Promotes Retinal Neovascularization in a Mouse Model of Oxygen-Induced Retinopathy Investigative Ophthalmology & Visual Science July 2022, Vol.63, 9

https://pubmed.ncbi.nlm.nih.gov/35816041

4. himpanzee adenovirus-mediated multiple gene therapy for age-related macular degeneration.Published:September 15, 2023

https://doi.org/10.1016/j.isci.2023.10793

5. Potential role of nitrogen in spore dispersal and infection of Paraphysoderma sedebokerense, a fungal parasite of Haematococcus pluvialis Received 2 April 2021 

https://doi.org/10.1016/j.algal.2021.102552

6. Injectable Living Probiotic Dressing Built by Droplet-Based Microfluidics and Photo-Cross-Linking to Prevent Pathogenic Infection and Promote Wound Repair.16 October 2023 

https://doi.org/10.1002/adhm.202302423

7. Single?cell transcriptomics reveal the crosstalk between plate- 1 let-associated TRAF4high endothelial cell subpopulation and 2 tumor microenvironment in colorectal cancer 

https://doi.org/10.21203/rs.3.rs-4506500/v1

8. Chimpanzee adenovirus-mediated multiple gene therapy for age-related macular degeneration

https://doi.org/10.1016/j.isci.2023.107939

9. LncRNA-MM2P regulates retinal neovascularization through M2 macrophage polarization author links open overlay 

https://doi.org/10.1016/j.exer.2024.110072

10. Haixiang Zhou, Bingyan Li, Zicong Wang , Yuting Cai , Shigeo Yoshida , Yedi Zhou, Yun Li,HO-1-mediated ferroptosis regulates retinal neovascularization via the COX2/VEGFA axis

https://doi.org/10.1016/j.freeradbiomed.2024.11.017

11. Shen, W., Han, G., Yu, L., Yang, S., Li, X., Zhang, W., & Pei, P. (2022). Combined Prussian Blue Nanozyme Carriers Improve Photodynamic Therapy and Effective Interruption of Tumor Metastasis. International Journal of Nanomedicine, 17, 1397–1408

https://doi.org/10.2147/IJN.S359156

12. Exploring PU.1 as a Therapeutic Target to Mitigate Oxidative Stress and Inflammation in Peritoneal Dialysis-Induced Peritoneal Fibrosis

https://doi.org/10.1096/fj.202500305RR

13. Biomimetic nanoparticles facilitate homologous targeting and radiosensitivity in glioblastoma cells

https://doi.org/10.1016/j.mtnano.2025.100676

14. M2 Macrophage-Derived Migrasomes Mediate Ischaemia-Induced Retinal Neovascularization by Targeting TREM2,First published: 31 October 2025

https://doi.org/10.1002/jev2.70180

FGCM成纖維細胞培養基

成纖維細胞是疏松結締組織的主要細胞成分，細胞呈梭形或扁的星狀，具有突起。根據不同的功能活動狀態，將細胞分為成纖維細胞和纖維細胞二型，成纖維細胞培養基是由2%的低血清和小分子化合物組合而成，培養基含有維生素、轉金屬蛋白、谷氨酰胺、脂類濃縮劑、抗氧化劑、嘌呤、糖類和細胞生長因子等可維持細胞體外生長所需的營養成分，適合大部分成纖維細胞的生長。

培養基配方：

成纖維細胞基礎培養基(貨號：P6000)：500ml  ，細胞生長因子FGCS(貨號：P6002)：5ml ，胎牛血清FBS（貨號：SD0200）：10ml，G/A(貨號：SD0038)：5ml

備注：100ml瓶裝無套件，為整瓶配制。

聲明：產品僅供科研使用。

參考文獻/Publications

1. Structural and biofunctional evaluation of decellularized jellyfish matrices，DOI;

https://doi.org/10.1039/D3TB00428G

2. Collagen from Iris squid grafted with polyethylene glycol and collagen peptides promote the proliferation of fibroblast through PI3K/AKT and Ras/RAF/MAPK signaling pathways，

https://doi.org/10.1016/j.ijbiomac.2023.125772